☰

Sanjeevani Arora, Ph.D. - Publications

Affiliations: 
2012 College of Medicine The University of Toledo 
Area:
Molecular Biology, Biochemistry, Oncology
Tree Info Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chandramouly G, Jamsen J, Borisonnik N, Tyagi M, Calbert ML, Tredinnick T, Ozdemir AY, Kent T, Demidova EV, Arora S, Wilson SH, Pomerantz RT. Polλ promotes microhomology-mediated end-joining. Nature Structural & Molecular Biology. PMID 36536104 DOI: 10.1038/s41594-022-00895-4  0.349
2022 Shah SM, Demidova EV, Lesh RW, Hall MJ, Daly MB, Meyer JE, Edelman MJ, Arora S. Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. Cancer Treatment Reviews. 104: 102337. PMID 35051883 DOI: 10.1016/j.ctrv.2021.102337  0.446
2021 Iqbal W, Demidova EV, Serrao S, ValizadehAslani T, Rosen G, Arora S. RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy. Frontiers in Genetics. 12: 628758. PMID 33868369 DOI: 10.3389/fgene.2021.628758  0.4
2020 Hartman TR, Demidova EV, Lesh RW, Hoang L, Richardson M, Forman A, Kessler L, Speare V, Golemis EA, Hall MJ, Daly MB, Arora S. Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer. Scientific Reports. 10: 13518. PMID 32782288 DOI: 10.1038/S41598-020-70449-5  0.402
2020 Arora S, Xiu J, Sohal D, Lou E, Goldberg RM, Weinberg BA, Grothey A, Korn WM, Khushman M, Shields AF, Marshall J, Hall MJ. The landscape of POLE variants in colorectal and endometrial tumors: Correlation with microsatellite instability (MSI) and tumor mutation burden (TMB). Journal of Clinical Oncology. 38: e13538-e13538. DOI: 10.1200/Jco.2020.38.15_Suppl.E13538  0.333
2019 Serebriiskii IG, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, Ali S, Ross JS, Handorf E, Arora S, Lieu C, Golemis EA, Meyer JE. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nature Communications. 10: 3722. PMID 31427573 DOI: 10.1038/S41467-019-11530-0  0.301
2019 Arora S, Velichinskii R, Lesh RW, Ali U, Kubiak M, Bansal P, Borghaei H, Edelman MJ, Boumber Y. Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors. Advances in Therapy. PMID 31410780 DOI: 10.1007/S12325-019-01051-Z  0.375
2019 Arora S, Demidova E, Avkshtol V, Lesh R, Browne AJ, Handorf EA, Golemis E, Meyer JE. Correlation of peripheral blood markers of DNA damage and immune response with chemoradiation response in patients with locally advanced rectal cancer. Journal of Clinical Oncology. 37: e15109-e15109. DOI: 10.1200/Jco.2019.37.15_Suppl.E15109  0.468
2018 Heyza JR, Arora S, Zhang H, Conner KL, Lei W, Floyd AM, Deshmukh RR, Sarver J, Trabbic CJ, Erhardt P, Chan TH, Dou QP, Patrick SM. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 10. PMID 30400270 DOI: 10.3390/Nu10111644  0.641
2018 Arora S, Heyza JR, Chalfin EC, Ruch RJ, Patrick SM. Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling. Cancers. 10. PMID 30279363 DOI: 10.3390/Cancers10100368  0.605
2017 Arora S, Huwe PJ, Sikder R, Shah M, Browne AJ, Lesh R, Nicolas E, Deshpande S, Hall MJ, Dunbrack RL, Golemis EA. Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods. Cancer Biology & Therapy. 0. PMID 28494185 DOI: 10.1080/15384047.2017.1326439  0.422
2017 Avkshtol V, Arora S, Lesh R, Golemis E, Egleston B, Meyer J. Peripheral Blood Lymphocyte Gamma-H2AX as a Predictor for Treatment Response in Rectal Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 99: E576-E577. DOI: 10.1016/J.Ijrobp.2017.06.1988  0.307
2016 Arora S, Heyza J, Zhang H, Kalman-Maltese V, Tillison K, Floyd AM, Chalfin EM, Bepler G, Patrick SM. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Oncotarget. PMID 27650543 DOI: 10.18632/Oncotarget.12072  0.63
2016 Nicolas E, Golemis EA, Arora S. POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies. Gene. PMID 27320729 DOI: 10.1016/J.Gene.2016.06.031  0.46
2016 Vinogradova M, Gehling VS, Gustafson A, Arora S, Tindell CA, Wilson C, Williamson KE, Guler GD, Gangurde P, Manieri W, Busby J, Flynn EM, Lan F, Kim HJ, Odate S, et al. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nature Chemical Biology. PMID 27214401 DOI: 10.1038/Nchembio.2085  0.308
2016 Arora S, Huwe PJ, Sikder R, Shah M, Deshpande S, Hall MJ, Dunbrack RL, Golemis EA. Abstract 5286: A pipeline for developing a novel, predictive tool to classify variants of uncertain significance (VUS) in Lynch Syndrome Cancer Research. 76: 5286-5286. DOI: 10.1158/1538-7445.Am2016-5286  0.404
2015 Nicolas E, Arora S, Zhou Y, Serebriiskii IG, Andrake MD, Handorf ED, Bodian DL, Vockley JG, Dunbrack RL, Ross EA, Ealeston B, Hall MJ, Golemis EA, Giri VN, Daly MB. Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer. Oncotarget. PMID 26485759 DOI: 10.18632/Oncotarget.5554  0.419
2015 Arora S, Yan H, Cho I, Fan HY, Luo B, Gai X, Bodian DL, Vockley JG, Zhou Y, Handorf E, Egleston BL, Andrake M, Nicolas E, Serebriiskii I, Yen TJ, et al. Genetic Variants That Presdispose to DNA Double-strand Breaks in Lymphocytes from a Subset of Patients With Familial Colorectal Carcinomas. Gastroenterology. PMID 26344056 DOI: 10.1053/J.Gastro.2015.08.052  0.435
2015 arora s, Yan H, Cho I, Fan H, Luo B, gai x, bodian d, vockley j, zhou y, handorf e, andrake m, nicolas e, Serebriiskii I, yen t, hall m, et al. Abstract 4739: Genetic predisposition to DNA double strand break repair defect defines a new class of familial colon cancer Cancer Research. 75: 4739-4739. DOI: 10.1158/1538-7445.Am2015-4739  0.451
2010 Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. Dna Repair. 9: 745-53. PMID 20418188 DOI: 10.1016/J.Dnarep.2010.03.010  0.631
Show low-probability matches.